Laboratory Financial Statements From 2010 to 2024

LH Stock  USD 201.48  2.03  1.02%   
Laboratory financial statements provide useful quarterly and yearly information to potential Laboratory of investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Laboratory financial statements helps investors assess Laboratory's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Laboratory's valuation are summarized below:
Gross Profit
4.4 B
Profit Margin
0.0344
Market Capitalization
16.8 B
Enterprise Value Revenue
1.8686
Revenue
12.2 B
We have found one hundred twenty available fundamental ratios for Laboratory, which can be analyzed and compared to other ratios and to its peers in the industry. Traders should compare all of Laboratory last-minute fundamentals against the fundamentals between 2010 and 2024 to make sure the company is sustainable this year. The Laboratory's current Market Cap is estimated to increase to about 7.2 B. The Laboratory's current Enterprise Value is estimated to increase to about 8.7 B

Laboratory Total Revenue

12.77 Billion

Check Laboratory financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Laboratory main balance sheet or income statement drivers, such as Interest Expense of 209.6 M, Total Revenue of 12.8 B or Gross Profit of 1.9 B, as well as many exotic indicators such as Price To Sales Ratio of 1.6, Dividend Yield of 0.0122 or PTB Ratio of 3.27. Laboratory financial statements analysis is a perfect complement when working with Laboratory Valuation or Volatility modules.
  
This module can also supplement Laboratory's financial leverage analysis and stock options assessment as well as various Laboratory Technical models . Check out the analysis of Laboratory Correlation against competitors.

Laboratory Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Common Stock Shares Outstanding96 M87.6 M93.2 M
Slightly volatile
Total Assets17.6 B16.7 B13.5 B
Slightly volatile
Other Current Liabilities502.9 M804 M743.7 M
Slightly volatile
Total Current Liabilities3.4 B3.2 B2.1 B
Slightly volatile
Total Stockholder Equity8.3 B7.9 B5.9 B
Slightly volatile
Property Plant And Equipment Net3.1 B2.9 B1.8 B
Slightly volatile
Retained Earnings8.3 B7.9 B6.1 B
Slightly volatile
Accounts Payable868.9 M827.5 M528 M
Slightly volatile
Cash290.8 M536.8 M528.3 M
Slightly volatile
Non Current Assets Total13.6 B13 B10.7 B
Slightly volatile
Non Currrent Assets Other270.8 M536.5 M312.1 M
Slightly volatile
Cash And Short Term Investments299.7 M536.8 M528.9 M
Slightly volatile
Net Receivables2.2 B2.1 B1.7 B
Slightly volatile
Liabilities And Stockholders Equity17.6 B16.7 B13.5 B
Slightly volatile
Non Current Liabilities Total3.1 B5.6 B5.5 B
Slightly volatile
Other Current Assets688.1 M655.3 M341.8 M
Slightly volatile
Total Liabilities9.3 B8.8 B7.5 B
Slightly volatile
Total Current AssetsB3.8 B2.8 B
Slightly volatile
Short and Long Term Debt Total6.3 BBB
Slightly volatile
Intangible AssetsB3.3 B2.8 B
Slightly volatile
Short Term Debt1.2 B1.2 B594.7 M
Very volatile
Inventory498.3 M474.6 M260.1 M
Slightly volatile
Property Plant And Equipment Gross6.1 B5.8 B2.5 B
Slightly volatile
Common Stock Total Equity12.2 M9.8 M10 M
Pretty Stable
Other Liabilities702.7 M1.2 BB
Slightly volatile
Other Assets531.7 M506.3 M293.6 M
Slightly volatile
Long Term Debt3.1 B4.1 B4.2 B
Slightly volatile
Property Plant Equipment3.6 B3.4 B1.9 B
Slightly volatile
Good Will4.4 B6.1 B5.5 B
Slightly volatile
Long Term Debt Total4.8 B5.9 B4.5 B
Slightly volatile
Long Term Investments25.6 M26.9 M66 M
Slightly volatile
Non Current Liabilities Other135.2 M142.3 M291.1 M
Pretty Stable
Short and Long Term DebtB999.8 M416.2 M
Slightly volatile
Capital Lease Obligations665.4 M899.7 M395.7 M
Slightly volatile
Cash And Equivalents744.5 M494.5 M571.9 M
Slightly volatile
Net Invested Capital15.6 B12.9 B14 B
Slightly volatile
Net Working Capital513.2 M540.2 M904.6 M
Slightly volatile
Capital Stock7.2 M7.7 M10.3 M
Slightly volatile

Laboratory Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Total Revenue12.8 B12.2 B9.7 B
Slightly volatile
Gross Profit1.9 B3.1 BB
Slightly volatile
Operating Income832.3 M1.1 B1.3 B
Slightly volatile
EBIT865.8 M1.1 B1.4 B
Slightly volatile
EBITDA1.1 B1.7 B1.8 B
Slightly volatile
Depreciation And Amortization609.9 M580.9 M487.3 M
Slightly volatile
Other Operating Expenses11.6 B11 B8.2 B
Slightly volatile
Cost Of Revenue9.5 BB6.6 B
Slightly volatile
Total Operating Expenses1.1 BB1.6 B
Slightly volatile
Income Before Tax748.7 M568.9 M1.2 B
Slightly volatile
Net Income513.9 M418 M836.1 M
Slightly volatile
Selling General Administrative1.1 B2.2 B1.5 B
Slightly volatile
Non Recurring48.2 M49.6 M48 M
Very volatile
Non Operating Income Net Other95.6 M91.1 M52.8 M
Slightly volatile
Interest Income166.7 M149.4 M219.9 M
Slightly volatile
Reconciled Depreciation679.5 M658 M582.4 M
Slightly volatile

Laboratory Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Free Cash Flow619.8 M874.1 M978.9 M
Slightly volatile
Begin Period Cash Flow265.8 M320.6 M497.6 M
Slightly volatile
Depreciation609.9 M580.9 M450.9 M
Slightly volatile
Capital Expenditures476.3 M453.6 M309 M
Slightly volatile
Total Cash From Operating Activities801.6 M1.3 B1.3 B
Slightly volatile
Net Income514.7 M379.2 M835.7 M
Slightly volatile
Stock Based Compensation82.9 M128.7 M88.9 M
Slightly volatile
Issuance Of Capital Stock46.2 M54.4 M63 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.61.62781.4229
Pretty Stable
Dividend Yield0.01220.01280.0848
Slightly volatile
PTB Ratio3.272.51392.3716
Pretty Stable
Days Sales Outstanding68.4562.987260.2396
Slightly volatile
Book Value Per Share94.9390.413362.7141
Slightly volatile
Free Cash Flow Yield0.05920.04420.0785
Pretty Stable
Invested Capital1.290.66370.9564
Pretty Stable
Operating Cash Flow Per Share16.0115.243413.8628
Slightly volatile
Stock Based Compensation To Revenue0.01840.01060.0106
Very volatile
PB Ratio3.272.51392.3716
Pretty Stable
EV To Sales1.942.07331.7993
Very volatile
Free Cash Flow Per Share10.5410.035610.5558
Slightly volatile
ROIC0.05450.05730.0962
Slightly volatile
Inventory Turnover31.7218.998128.0547
Pretty Stable
Net Income Per Share3.854.79918.683
Slightly volatile
Days Of Inventory On Hand10.4219.212413.2977
Slightly volatile
Payables Turnover16.6510.896113.4581
Pretty Stable
Sales General And Administrative To Revenue0.20.210.2266
Very volatile
Cash Per Share6.476.1635.8381
Slightly volatile
POCF Ratio12.3614.910710.0342
Pretty Stable
Payout Ratio0.640.60771.1473
Slightly volatile
PFCF Ratio23.7822.648413.9994
Slightly volatile
Days Payables Outstanding20.5433.498327.7664
Very volatile
Income Quality3.683.50131.775
Slightly volatile
ROE0.05040.05310.1534
Slightly volatile
EV To Operating Cash Flow16.5918.99113.3851
Slightly volatile
PE Ratio49.7347.361118.787
Slightly volatile
Return On Tangible Assets0.05480.05770.1813
Slightly volatile
EV To Free Cash Flow30.2928.846118.5312
Slightly volatile
Earnings Yield0.03450.02110.0676
Slightly volatile
Intangibles To Total Assets0.460.56710.623
Slightly volatile
Current Ratio1.761.16751.5456
Pretty Stable
Receivables Turnover4.985.79486.1872
Slightly volatile
Graham Number10498.8067108
Slightly volatile
Shareholders Equity Per Share94.9390.413362.7141
Slightly volatile
Debt To Equity1.290.66370.9564
Pretty Stable
Average ReceivablesB2.3 B2.5 B
Slightly volatile
Revenue Per Share147140103
Slightly volatile
Interest Debt Per Share65.4162.299754.985
Slightly volatile
Debt To Assets0.440.31250.3884
Pretty Stable
Enterprise Value Over EBITDA10.3814.7929.0947
Slightly volatile
Short Term Coverage Ratios1.081.13288.1332
Very volatile
Price Earnings Ratio49.7347.361118.787
Slightly volatile
Operating Cycle58.7182.199771.3336
Slightly volatile
Price Book Value Ratio3.272.51392.3716
Pretty Stable
Days Of Payables Outstanding20.5433.498327.7664
Very volatile
Dividend Payout Ratio0.640.60771.1473
Slightly volatile
Price To Operating Cash Flows Ratio12.3614.910710.0342
Pretty Stable
Price To Free Cash Flows Ratio23.7822.648413.9994
Slightly volatile
Pretax Profit Margin0.04440.04680.1301
Slightly volatile
Ebt Per Ebit0.990.50630.8713
Pretty Stable
Operating Profit Margin0.180.09240.1558
Slightly volatile
Company Equity Multiplier2.822.12382.3422
Very volatile
Long Term Debt To Capitalization0.470.33990.4301
Very volatile
Total Debt To Capitalization0.530.39890.4639
Very volatile
Return On Capital Employed0.07910.08320.1497
Slightly volatile
Debt Equity Ratio1.290.66370.9564
Pretty Stable
Ebit Per Revenue0.180.09240.1558
Slightly volatile
Quick Ratio1.430.81721.2904
Pretty Stable
Net Income Per E B T0.420.73480.6871
Pretty Stable
Cash Ratio0.310.16640.3593
Slightly volatile
Cash Conversion Cycle52.4948.701444.5218
Slightly volatile
Operating Cash Flow Sales Ratio0.10.10920.1364
Slightly volatile
Days Of Inventory Outstanding10.4219.212413.2977
Slightly volatile
Days Of Sales Outstanding68.4562.987260.2396
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.510.65840.7388
Slightly volatile
Cash Flow Coverage Ratios0.240.2540.579
Slightly volatile
Price To Book Ratio3.272.51392.3716
Pretty Stable
Fixed Asset Turnover7.954.17676.5462
Slightly volatile
Price Cash Flow Ratio12.3614.910710.0342
Pretty Stable
Enterprise Value Multiple10.3814.7929.0947
Slightly volatile
Debt Ratio0.440.31250.3884
Pretty Stable
Cash Flow To Debt Ratio0.240.2540.579
Slightly volatile
Price Sales Ratio1.61.62781.4229
Pretty Stable
Return On Assets0.02370.0250.0709
Slightly volatile
Asset Turnover1.010.72710.7801
Slightly volatile
Net Profit Margin0.06740.03440.0923
Slightly volatile
Gross Profit Margin0.420.25860.351
Slightly volatile
Price Fair Value3.272.51392.3716
Pretty Stable
Return On Equity0.05040.05310.1534
Slightly volatile

Laboratory Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap7.2 B6.8 B7.1 B
Slightly volatile
Enterprise Value8.7 B8.3 B8.5 B
Slightly volatile

Laboratory Fundamental Market Drivers

Forward Price Earnings13.8504
Cash And Short Term Investments536.8 M

Laboratory Upcoming Events

15th of February 2024
Upcoming Quarterly Report
View
23rd of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
15th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Laboratory Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Laboratory income statement, its balance sheet, and the statement of cash flows. Laboratory investors use historical funamental indicators, such as Laboratory's revenue or net income, to determine how well the company is positioned to perform in the future. Although Laboratory investors may use each financial statement separately, they are all related. The changes in Laboratory's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Laboratory's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Laboratory Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Laboratory. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue421.7 M442.8 M
Total Revenue12.2 B12.8 B
Cost Of RevenueB9.5 B
Stock Based Compensation To Revenue 0.01  0.02 
Sales General And Administrative To Revenue 0.21  0.20 
Research And Ddevelopement To Revenue 0.00  0.00 
Capex To Revenue(0.04)(0.04)
Revenue Per Share 139.63  146.61 
Ebit Per Revenue 0.09  0.18 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Laboratory offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Laboratory's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Laboratory Of Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Laboratory Of Stock:
Check out the analysis of Laboratory Correlation against competitors.
Note that the Laboratory information on this page should be used as a complementary analysis to other Laboratory's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Complementary Tools for Laboratory Stock analysis

When running Laboratory's price analysis, check to measure Laboratory's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Laboratory is operating at the current time. Most of Laboratory's value examination focuses on studying past and present price action to predict the probability of Laboratory's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Laboratory's price. Additionally, you may evaluate how the addition of Laboratory to your portfolios can decrease your overall portfolio volatility.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Is Laboratory's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Laboratory. If investors know Laboratory will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Laboratory listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.46)
Dividend Share
2.88
Earnings Share
4.34
Revenue Per Share
139.628
Quarterly Revenue Growth
0.035
The market value of Laboratory is measured differently than its book value, which is the value of Laboratory that is recorded on the company's balance sheet. Investors also form their own opinion of Laboratory's value that differs from its market value or its book value, called intrinsic value, which is Laboratory's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Laboratory's market value can be influenced by many factors that don't directly affect Laboratory's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Laboratory's value and its price as these two are different measures arrived at by different means. Investors typically determine if Laboratory is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Laboratory's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.